Viking Therapeutics Newsroom

'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape

BenzingaDec 4 01:11

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?

Yahoo FinanceDec 3 21:27

Corbus, Viking Initiated at Overweight by Piper Sandler

Seeking AlphaDec 3 02:34

This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

BenzingaDec 2 21:56

Piper Sandler Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $74

Futu NewsDec 2 18:34 · Ratings

Express News | Viking Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $74

BreakingsDec 2 17:16

Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum

BenzingaNov 29 21:42

Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow

Yahoo FinanceNov 29 02:17

Is weight loss medication including in usa medical insurance, becoming the strongest 'roadblock' for the Trump team?

"Weight loss duo" leads significant increase.

Gelonghui FinanceNov 27 09:45

BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125

Futu NewsNov 27 06:31 · Ratings

Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline

MT NewswiresNov 27 05:00

H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102

Futu NewsNov 27 01:32 · Ratings

HC Wainwright & Co. Reiterates Buy on Viking Therapeutics, Maintains $102 Price Target

BenzingaNov 27 00:47 · Ratings

Press Release: Viking Mergers & Acquisitions Announces Key Promotions in Florida Division, Showcasing Internal Growth-Focused Culture and Leadership

Dow JonesNov 27 00:34

Express News | US weight loss drug concept stocks rose across the board, with Viking Therapeutics up more than 5%, Altimmune and Eli Lilly and Co up more than 3%, Sorrento Biologicals and Novo-Nordisk A/S up more than 2%. Previously, US President Biden proposed medical

BreakingsNov 26 22:52

Amgen (AMGN.US) releases mid-term data for weight loss therapy MariTide, with weight loss results comparable to Novartis.

Amgen announced on Tuesday that its experimental weight loss therapy MariTide has achieved significant results in Phase 2 trials.

Zhitong FinanceNov 26 21:38

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs

WSJNov 26 18:37

Positive Phase 2 Trial Results Drive Viking Therapeutics (VKTX) Stock Upwards

TipRanksNov 25 18:16

Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?

Yahoo FinanceNov 23 00:31

How Is The Market Feeling About Viking Therapeutics?

BenzingaNov 23 00:15